Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -0.38% | 0.00% | +11.81% |
04-03 | Kinnate Biopharma Inc. Announces Board Resignations | CI |
04-03 | Kinnate Biopharma Inc.(NasdaqGS:KNTE) dropped from NASDAQ Composite Index | CI |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Quah Cheng
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/05/20 |
Priyanka Shah
IRC | Investor Relations Contact | - | - |
Barbara Warren
HRO | Human Resources Officer | - | 31/12/20 |
Jason Hampson
LAW | General Counsel | - | 06/06/21 |
David Madden
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,225,312 | 47,161,396 ( 99.86 %) | 0 | 99.86 % |
Company contact information
Kinnate Biopharma, Inc.
12830 El Camino Real Suite 150
92130, San Diego
+858-299-4699
http://www.kinnate.comSector
1st Jan change | Capi. | |
---|---|---|
+11.81% | 125M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- KNTE Stock
- Company Kinnate Biopharma Inc.